# Immunic (IMUX) — Analyst Forecast

IMUX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/imux/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 12 | 0 | 0 | 12 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 10, 2026 | HC Wainwright & Co. | Maintained | Buy | $22.00 |
| Sep 10, 2026 | Wedbush | Maintained | Outperform | $45.00 |
| Aug 17, 2026 | Wedbush | Initiated Coverage | Outperform | $45.00 |
| May 22, 2026 | B. Riley Securities | Maintained | Buy | $27.00 |
| Apr 30, 2026 | HC Wainwright & Co. | Maintained | Buy | $22.00 |
| Apr 17, 2026 | Stifel | Initiated Coverage | Buy | $2.50 |
| Apr 15, 2026 | D. Boral Capital | Downgraded | Buy → Hold | — |
| Mar 24, 2026 | Guggenheim | Initiated Coverage | Buy | $7.00 |
| Mar 2, 2026 | HC Wainwright & Co. | Maintained | Buy | $5.00 |
| Feb 13, 2026 | D. Boral Capital | Maintained | Buy | $4.00 |
| Feb 9, 2026 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Jan 7, 2026 | D. Boral Capital | Maintained | Buy | $8.00 |
| Nov 14, 2025 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Nov 13, 2025 | D. Boral Capital | Maintained | Buy | $8.00 |
| Sep 29, 2025 | Chardan Capital | Initiated Coverage | Buy | $3.00 |
| Sep 26, 2025 | HC Wainwright & Co. | Maintained | Buy | $10.00 |
| Sep 25, 2025 | D. Boral Capital | Maintained | Buy | $10.00 |
| Aug 8, 2025 | D. Boral Capital | Maintained | Buy | $10.00 |
| Jun 25, 2025 | D. Boral Capital | Maintained | Buy | $10.00 |
| Jun 5, 2025 | D. Boral Capital | Maintained | Buy | $10.00 |

## Frequently Asked Questions

### Is IMUX a buy, sell, or hold?

Analysts covering Immunic currently average a Buy rating: 12 buy, 0 hold and 0 sell, from 12 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on IMUX?

On Sep 10, 2026, HC Wainwright & Co. maintained Immunic at Buy with a price target of $22.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).